Cargando…
Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma
Introduction: Merkel cell carcinoma (MCC) is an aggressive skin cancer, related to the Merkel Cell Polyomavirus (MCPyV) in 80% of cases. Immune checkpoint inhibitors provide sustained benefit in about 50% of MCC patients with advanced disease. Glypican-3 (GPC3) is an oncofetal tumor antigen that is...
Autores principales: | Muralidharan, Sujatha, Kervarrec, Thibault, Weiss, Glen J., Samimi, Mahtab |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348696/ https://www.ncbi.nlm.nih.gov/pubmed/35937502 http://dx.doi.org/10.18632/oncotarget.28260 |
Ejemplares similares
-
Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy
por: Goh, Gerald, et al.
Publicado: (2015) -
Merkel Cell Carcinoma of Unknown Primary: Immunohistochemical and Molecular Analyses Reveal Distinct UV-Signature/MCPyV-Negative and High Immunogenicity/MCPyV-Positive Profiles
por: Donizy, Piotr, et al.
Publicado: (2021) -
Detection of Merkel Cell Polyomavirus (MCPyV) DNA and Transcripts in Merkel Cell Carcinoma (MCC)
por: Passerini, Sara, et al.
Publicado: (2023) -
Merkel Cell Polyomavirus (MCPyV) and Cancers: Emergency Bell or False Alarm?
por: Dimitraki, Maria Georgia, et al.
Publicado: (2022) -
Prevalence of Merkel Cell Polyomavirus (MCPyV) in the Oral Cavity Biopsies in Northern Iran
por: Hasani Estalkhi, Mina, et al.
Publicado: (2021)